Helen Torley, President and CEO: Halozyme Therapeutics HALO Planned sale · Filed 08/17

Trade details

Type: Planned sale notice
Stock: Halozyme Therapeutics HALO
Person: Helen TorleyPresident and CEO
Planned sale date: 26/08/17
Filed: 26/08/17

More to sell after $3.5M in 3 months

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 07/18~09/16

Helen Torley's recent trades

Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$1.1M
16,600 sh
$1.1M
Filed 06/03
Traded 06/02
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$875.6K
12,989 sh
$875.6K
Filed 06/03
Traded 06/01
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$425.1K
6,100 sh
$425.1K
Filed 06/03
Traded 06/03
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$369.2K
5,401 sh
$369.2K
Filed 06/03
Traded 06/01
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$227K
3,400 sh
$227K
Filed 06/03
Traded 06/02

Helen Torley, CEO — plans to sell 240,000 sh of Halozyme Therapeutics HALO · $23.7M · around 08/17 · 10b5-1 plan | Whalegun